Clinical Research Directory
Browse clinical research sites, groups, and studies.
StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias
Sponsor: University Health Network, Toronto
Summary
This is a prospective, single-center, phase II trial that will be monitoring the safety and efficacy of using stereotactic ablative radiotherapy (SBRT) to treat patients with a medical condition affecting heart rate and rhythm (refractory arrhythmias) within the University Health Network (Princess Margaret Cancer Centre and Toronto General Hospital). The primary objective will be to prospectively monitor patient cardiac outcomes following SBRT.
Official title: StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA): a Phase II Trial of Non-Invasive Treatment of Medically Refractory Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2021-12-14
Completion Date
2027-12
Last Updated
2026-03-05
Healthy Volunteers
No
Conditions
Interventions
Stereotactic Ablative Radiotherapy
Stereotactic ablative radiotherapy (SBRT) is a type of radiation treatment that delivers precise, high dose radiation to targeted areas. In this study, a single treatment of SBRT will be delivered to the abnormal area of a participant's heart that is causing dangerous heart rate and rhythm changes (arrhythmia).
Locations (1)
Princess Margaret Cancer Center, University Health Network
Toronto, Ontario, Canada